Mondelez Retail Investors Unimpressed After Wells Fargo Upgrades Rating

Published : Jun 23, 2025, 03:10 PM IST
https://stocktwits.com/news-articles/markets/equity/mondelez-retail-investors-unimpressed-after-wells-fargo-upgrades-rating/chmPU0QRR5V

Synopsis

The investment firm noted that price hikes, low inflation risk, and a weak valuation make for a strong bull case for the stock.

Wells Fargo raised its rating and price target on Mondelez International (MDLZ) shares, sending the stock up 3% on Friday. However, it failed to have an impact on retail investors' sentiment, which remained low.

The investment advisor upgraded the rating to 'Overweight' from 'Equal Weight.' The price target was raised to $78, up from $68, indicating a 14% upside from current levels.

"While the company is confronting historical inflation in 2025, 1) pricing execution has been strong, 2) inflation looks likely to temper in 2026, and we see a recovery of earnings ahead," the analysts wrote, according to The Fly.

The low relative valuation creates the "optimal bull case." Mondelez shares are up 14.4% year-to-date.

The recent decline in cocoa prices may also provide some tailwinds. Mondelez is best known for Cadbury chocolates, Oreo biscuits, and Bournvita drink mix and has dozens of other popular products.

Currently, 19 of the 27 analysts covering the stock rate it 'buy' or higher, and eight rate it 'hold,' according to Koyfin data. Their average price target is $63.31.

On Stocktwits, the retail sentiment for Mondelez was 'bearish,' unchanged from a month ago.

The latest rating action comes as Mondelez reported higher-than-expected profit in the last quarter, helped by several rounds of price hikes and new product launches.

The company also maintained its annual forecast, even as peer consumer majors like Kraft Heinz, General Mills, and PepsiCo have trimmed theirs.

For updates and corrections, email newsroom[at]stocktwits[dot]com.<

PREV

Recommended Stories

Kala Bio Stock Soars 22% After Hours As Emergency Financing Deal Averts Asset Seizure After Eye Disease Drug Trial Collapse
Zscaler Stock Tanks After Hours Despite Handy Earnings Beat: What Gives?